nandixon
Senior Member
- Messages
- 1,092
I was researching a class of drugs called "fibrates" and came across this recent (2015) article which describes Clostridium butyricum MIYAIRI 588 doing, possibly, the very thing I was hoping a fibrate might (i.e., overcome impaired oxidation of fatty acids).
An interesting point is that under the mouse model conditions they used, they found it necessary to use both the bacteria and the prebiotic inulin, and that neither one alone achieved a significant result.
Whether using inulin is ideal in our individual cases is another matter, but at least you know from this study that inulin does result in significant butyrate formation (in mice, anyway).
Induction of Peroxisomes by Butyrate-Producing Probiotics
An interesting point is that under the mouse model conditions they used, they found it necessary to use both the bacteria and the prebiotic inulin, and that neither one alone achieved a significant result.
Whether using inulin is ideal in our individual cases is another matter, but at least you know from this study that inulin does result in significant butyrate formation (in mice, anyway).
Induction of Peroxisomes by Butyrate-Producing Probiotics
In conclusion, elevation of butyrate availability (directly through administration of butyrate or indirectly via administration of butyrate-producing probiotics plus fiber) induces PPARα and Pex11a as well as genes involved in peroxisomal fatty acid β-oxidation, increases peroxisome abundance, and ultimately improves lipid metabolism.